Yeh Lab
Located within the UNC Lineberger Comprehensive Cancer Center, the Yeh Lab’s focus is to identify and study novel therapeutic targets for the treatment of pancreatic cancer. Pancreatic cancer in particular continues to be a lethal disease with few therapeutic options. Our research therefore centers on target identification through genomic, and more recently proteomic analyses of patient samples.
Learn More
Research
-
2021 World Pancreatic Cancer Day
2021 World Pancreatic Cancer Day Raising awareness for the fight against pancreatic cancer on World Pancreatic Cancer Day with our fellow Tar Heels at the UNC Lineberger Pancreatic Cancer Center of Excellence.
-
Joe Kearney, MD – Surgical Oncology Clinics Chapter Published
Congratulations to Joe Kearney, MD, on his chapter on Pathology and Molecular Characteristics of Pancreatic Cancer. in Surgical Oncology Clinics! Dr. Joe Kearney is a post-doctoral trainee in Yeh Lab.
-
Halloween 🎃
Yeh Lab celebrates Halloween through Zoom! 🎃
-
UNC CCBTP T32
Congratulations Maddy Jenner for acceptance into the UNC CCBTP (Cancer Cell Biology Training Program) T32! Maddy is currently a graduate student in Yeh Lab.
-
Joseph Kearney, MD, receives AHPBA 2021 Steve Sotsky Award
Dr. Kearney is a recipient of the Americas Hepato-Pancreato-Biliary Association 2021 Steve Sotsky Award. This annual award recognizes outstanding work in the field of pancreatic research by a trainee.
PANCREATIC CANCER NEWS
- Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism
- Aminopyridine analogs selectively target metastatic pancreatic cancer
- Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits